药物对比
Nateglinide vs Insulin Icodec
比较口服Nateglinide（氯茴苯酸类胰岛素促泌剂）与每周一次的insulin icodec（Awiqli）治疗糖尿病。作用机制、用途和适用性各不相同。
此页面暂无可用的对比维度。
临床背景
This comparison occurs when considering oral secretagogues versus initiating once-weekly basal insulin in type 2 diabetes intensification.
结论
Nateglinide and insulin icodec address different diabetes needs and are not interchangeable.
全部药物对比